To achieve specific gene transfer into human CD4+ cells, murine leukaemia virus (MLV)-based pseudotype vector particles were generated employing Env variants derived from human or simian immunodeficiency virus (HIV-1 or SIVagm). Here, we describe the generation of full-length onco/lentivirus hybrid genomes comprising components of MLV and HIV-1 or SIVagm, respectively, to assess the possibility of replication-competent hybrid virus formation. The env reading frame of an infectious molecular clone of MLV was replaced with the analogous coding regions of HIV-1 or SIVagm encompassing the env gene and accessory genes. Resulting MLV/HIV-1 or MLV/SIVagm hybrid genomes were transfected into 293T cells. Expression of viral proteins and budding of retroviral particles was shown by specific immunostaining and electron microscopy. The viral particles mediated CD4- and co-receptor-specific infection of human cells as demonstrated by PCR and immunostaining in the respective target cells. However, no productive infection resulting in the generation of infectious virus was detected in these cells. Thus, these onco/lentivirus hybrids, although able to initiate single-round infection, were not replication competent. Thus, MLV-based pseudotype vectors carrying Env variants of HIV-1 or SIVagm are not prone to form replication-competent retroviruses, suggesting a favourable safety profile for MLV-based CD4-specific pseudotype vectors.
AdachiA.,
GendelmanH. E.,
KoenigS.,
FolksT.,
WilleyR.,
RabsonA.,
MartinM. A.1986; Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59:284–291
BaierM.,
GarberC.,
MullerC.,
CichutekK.,
KurthR.1990; Complete nucleotide sequence of a simian immunodeficiency virus from African green monkeys: a novel type of intragroup divergence. Virology 176:216–221
CeciliaD.,
KewalRamaniV. N.,
O'LearyJ.,
VolskyB.,
NyambiP.,
BurdaS.,
XuS.,
LittmanD. R.,
Zolla-PaznerS.1998; Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J Virol 72:6988–6996
ChenB. K.,
RoussoI.,
ShimS.,
KimP. S.2001; Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells. Proc Natl Acad Sci U S A 98:15239–15244
ChongH.,
VileR. G.1996; Replication-competent retrovirus produced by a ‘split-function’ third generation amphotropic packaging cell line. Gene Ther 3:624–629
ChongH.,
StarkeyW.,
VileR. G.1998; A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences. J Virol 72:2663–2670
DonahueR. E.,
KesslerS. W.,
BodineD.7 other authors1992; Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 176:1125–1135
EdingerA. L.,
HoffmanT. L.,
SharronM.,
LeeB.,
O'DowdB.,
DomsR. W.1998; Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology 249:367–378
GelderblomH. R.,
HausmannE. H.,
ÖzelM.,
PauliG.,
KochM. A.1987; Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156:171–176
KönigR. R.,
FloryE.,
SteidlS.,
NeumannJ.,
CoulibalyC.,
HolznagelE.,
HolzammerS.,
NorleyS.,
CichutekK.2002; Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes. J Virol 76:10627–10636
LodgeR.,
SubbramanianR. A.,
ForgetJ.,
LemayG.,
CohenE. A.1998; MuLV-based vectors pseudotyped with truncated HIV glycoproteins mediate specific gene transfer in CD4+ peripheral blood lymphocytes. Gene Ther 5:655–664
MalmstenA.,
EkstrandD. H. L.,
AkerblomL.,
GronowitzJ. S.,
KällanderC. F. R.,
BendinelliM.,
MatteucciD.1998; A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity. J Virol Methods 75:9–20
MammanoF.,
SalvatoriF.,
IndraccoloS.,
De RossiA.,
Chieco-BianchiL.,
GöttlingerH.1997; Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells. J Virol 71:3341–3345
NasioulasG.,
ZolotukhinA. S.,
TaberneroC.,
SolominL.,
CunninghamC. P.,
PavlakisG. N.,
FelberB. K.1994; Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. J Virol 68:2986–2993
PurcellD. F.,
BrosciusC. M.,
VaninE. F.,
BucklerC. E.,
NienhuisA. W.,
MartinM. A.1996; An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer. J Virol 70:887–897
RoussoI.,
MixonM. B.,
ChenB. K.,
KimP. S.2000; Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity. Proc Natl Acad Sci U S A 97:13523–13525
SchnierleB. S.,
StitzJ.,
BoschV.,
NockenF.,
Merget-MillitzerH.,
EngelstädterM.,
KurthR.,
GronerB.,
CichutekK.1997; Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc Natl Acad Sci U S A 94:8640–8645
StitzJ.,
SteidlS.,
Merget-MillitzerH.9 other authors2000; MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients. Virology 267:229–236
WilkT.,
PfeiferT.,
BoschV.1992; Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 189:167–177